Primary versus elective percutaneous transluminal angioplasty with stenting for symptomatic intracranial atherosclerotic stenosis: a 18-centre retrospective cohort study using the pEGASUS-HPC stent
European Stroke Journal · 2026
DOI: 10.1093/esj/aakag091 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Stroke Journal, 2026. Verfasst von Ali Khanafer und 39 weiteren Autor:innen. Beteiligte Einrichtung: Neuroradiology, Klinikum Stuttgart Katharinenhospital, Stuttgart, Germany. Hauptthemen laut MEDLINE: Intracranial Arteriosclerosis, Stents, Angioplasty. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
To describe the safety and effectiveness of percutaneous transluminal angioplasty with pEGASUS-HPC stenting (PTAS) for symptomatic intracranial atherosclerotic stenosis (sICAS) and compare primary versus elective use. Patients and methods We retrospectively included consecutive adults with sICAS ≥50% treated with pEGASUS-HPC PTAS at 18 neurovascular centres (May 2021–February 2025). Primary PTAS was defined as treatment during non-large-vessel-occlusion acute ischaemic stroke (AIS); Elective PTAS was performed at least 7 days after the qualifying ischaemic presentation for recurrent symptoms or haemodynamic compromise despite intensive medical therapy. Outcomes included technical success (post-treatment stenosis ≤50% without intraprocedural complications), in-hospital major complications (intracerebral haemorrhage, AIS or death), restenosis and functional status, measured by the modified Rankin Scale (mRS) at last follow-up.
Results
Among 141 patients (Primary 71; Elective 70), median post-treatment stenosis was 23.0%; technical success was 94.3% (90.1% vs 98.6%; P = .063). In-hospital major complications occurred in 7.1% (12.7% Primary vs 1.4% Elective; P = .017), driven by intraprocedural in-stent thrombosis (9.9% vs 0%; P = .013). At last follow-up (median 9 months), restenosis ≥50% was observed in 14.3% (7.8% vs 19.7%; P = .10) and mRS <3 in 84.7% (82.1% vs 87.1%; P = .61). New diffusion-weighted imaging lesions were seen in 39.2% of 79 patients with early MRI, without group differences.
Discussion
In this multicentre cohort, pEGASUS-HPC PTAS provided substantial luminal gain, moderate restenosis and good mid-term functional outcomes overall. Elective use in medically refractory sICAS was associated with very low major complication rates, whereas primary use during AIS carried significantly higher thrombotic and haemorrhagic risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neuroradiology, Klinikum Stuttgart Katharinenhospital, Stuttgart, Germany.
- Diagnostic and Interventional Radiology and Neuroradiology, Alfried-Krupp-Hospital, Essen, Germany.
- Department of Neuroradiology, University Marburg, Marburg, Germany.
- Department of Neuroradiology, Clínica La Sagrada Familia, Buenos Aires, Argentina.
- Department of Neuroradiology, Nuremberg Hospital, Paracelsus Medical University, Nuremberg, Germany.
- Medical Centre Hospital of the President's Affairs Administration of the Republic of Kazakhstan, Astana City, Kazakhstan.
ORCID-Profile: Ivan Lylyk, Alexander Sirakov, Sebastian Johannes Müller, Stanimir Sirakov, Pedro Lylyk
Zitieren
APA
Khanafer, A., Ayad, A., Almohammad, M., Albiña-Palmarola, P., Lylyk, I., Eff, F., Mussabekov, I., Sirakov, A., Schüngel, M. S., Tonguc, T., Lobsien, D., Rückel, J., Anastasiou, A., AlMatter, M., Ali, Z., Dadak, M., Hajiyev, K., Allouche, M., von Gottberg, P., …, & Henkes, H. (2026). Primary versus elective percutaneous transluminal angioplasty with stenting for symptomatic intracranial atherosclerotic stenosis: a 18-centre retrospective cohort study using the pEGASUS-HPC stent. European Stroke Journal. https://doi.org/10.1093/esj/aakag091
Vancouver
Khanafer A, Ayad A, Almohammad M, Albiña-Palmarola P, Lylyk I, Eff F, et al. Primary versus elective percutaneous transluminal angioplasty with stenting for symptomatic intracranial atherosclerotic stenosis: a 18-centre retrospective cohort study using the pEGASUS-HPC stent. European Stroke Journal. 2026. doi:10.1093/esj/aakag091
BibTeX
@article{Khanafer2026,
author = {Khanafer, Ali and Ayad, Ahmed and Almohammad, Mohammad and Albiña-Palmarola, Pablo and Lylyk, Ivan and Eff, Florian and Mussabekov, Islambek and Sirakov, Alexander and Schüngel, Marie-Sophie and Tonguc, Tolga and Lobsien, Donald and Rückel, Johannes and Anastasiou, Aikaterini and AlMatter, Muhammad and Ali, Zakarya and Dadak, Mete and Hajiyev, Kamran and Allouche, Mehdi and von Gottberg, Philipp and Müller, Sebastian Johannes and Schüssler, Jonas and Hagiwara, Shinya and Aburub, Abdallah and Sarshayev, Marat and Bäzner, Hansjörg and Psychogios, Marios and Liebig, Thomas and Cohen, José E and Felber, Stephan and Klisch, Joachim and Dorn, Franziska and Sirakov, Stanimir and Holtmannspötter, Markus and Schob, Stefan and Berdikhojayev, Mynzhylky and Kemmling, André and Forsting, Michael and Lylyk, Pedro and Chapot, Rene and Henkes, Hans},
title = {Primary versus elective percutaneous transluminal angioplasty with stenting for symptomatic intracranial atherosclerotic stenosis: a 18-centre retrospective cohort study using the pEGASUS-HPC stent},
journal = {European Stroke Journal},
year = {2026},
doi = {10.1093/esj/aakag091}
}
EUVIMED